Vetsys Pharmaceutical
Vetsys Pharmaceutical
Advanced Intramammary Infusions Tailored for Local Dairy Farm Challenges
The dairy sector in Eswatini is a critical component of the national agricultural economy, driven by both smallholder farmers and large commercial estates in regions like Manzini and Lubombo. However, the sub-tropical climate poses significant challenges, most notably Bovine Mastitis, which remains the leading cause of economic loss for Swazi dairy producers.
High humidity and seasonal rainfall increase the microbial load in bedding and pasture, leading to higher somatic cell counts (SCC). Local farmers are increasingly seeking advanced Intramammary Infusions that offer both therapeutic efficacy for lactating cows and prophylactic protection during the "Dry Period." As a dedicated factory and supplier, we understand the logistical needs of the Eswatini market, providing long-shelf-life products that withstand local supply chain temperatures.
Setting the Benchmark for Veterinary Excellence
The global shift is moving toward Fourth-Generation Cephalosporins like Cefquinome Sulfate, which offer superior penetration into the udder tissue and lower resistance profiles.
Our products are backed by decades of Experience, scientific Expertise, and Authoritative GMP certifications, ensuring Trust with every dose.
Modern manufacturing now focuses on "Green Pharma," reducing chemical waste during synthesis while ensuring the syringe components are recyclable and eco-friendly.
Efficiency, Precision, and Scalability
Zhengzhou Vetsys Pharmaceutical Co., Ltd. represents the pinnacle of Chinese veterinary manufacturing. By centralizing the entire production chain—from raw material synthesis to the final mold injection of delivery syringes—we achieve a level of Information Gain in the supply chain that competitors cannot match.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. The facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
In Eswatini, the "Five-Point Plan" for mastitis control is widely recommended. Our intramammary infusions fit perfectly into this framework:
Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Full Range of Specialized Infusions for Eswatini Importers
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare in Eswatini and beyond.
